Expression of receptor activator of nuclear factor‐κB ligand by B cells in response to oral bacteria
- 14 April 2009
- journal article
- research article
- Published by Wiley in Oral Microbiology and Immunology
- Vol. 24 (3), 190-196
- https://doi.org/10.1111/j.1399-302x.2008.00494.x
Abstract
Introduction: We investigated receptor activator of nuclear factor‐κB ligand (RANKL) expression by B lymphocytes during early and late aspects of the immune response to Aggregatibacter actinomycetemcomitans, a gram‐negative, anaerobic bacterium associated with aggressive periodontal disease. Methods: Expression of messenger RNA transcripts (tumor necrosis factor‐α, Toll‐like receptors 4 and 9, interleukins 4 and 10, and RANKL) involved in early (1‐day) and late (10‐day) responses in cultured rat splenocytes was examined by reverse transcription–polymerase chain reaction (RT‐PCR). The immune cell distribution (T, B, and natural killer cells and macrophages) in cultured rat splenocytes and RANKL expression in B cells were determined by flow cytometric analyses. B‐cell capacity for induction of osteoclast differentiation was evaluated by coculture with RAW 264.7 cells followed by a tartrate‐resistant acid phosphatase (TRAP) activity assay. Results: The expression levels of interleukins 4 and 10 in cultured cells were not changed in the presence of A. actinomycetemcomitans until cultured for 3 days, and peaked after 7 days. After culture for 10 days, the percentages of B and T cells, the overall RANKL messenger RNA transcripts, and the percentage of RANKL‐expressing immunoglobulin G‐positive cells were significantly increased in the presence of A. actinomycetemcomitans. These increases were considerably greater in cells isolated from A. actinomycetemcomitans‐immunized animals than from non‐immunized animals. RAW 264.7 cells demonstrated significantly increased TRAP activity when cocultured with B cells from A. actinomycetemcomitans‐immunized animals. The addition of human osteoprotegerin‐Fc to the culture significantly diminished such increases. Conclusion: This study suggests that B‐lymphocyte involvement in the immune response to A. actinomycetemcomitans through upregulation of RANKL expression potentially contribute to bone resorption in periodontal disease.Keywords
This publication has 36 references indexed in Scilit:
- Macrophage-Elicited Osteoclastogenesis in Response to Bacterial Stimulation Requires Toll-Like Receptor 2-Dependent Tumor Necrosis Factor-Alpha ProductionInfection and Immunity, 2008
- Interference with immune‐cell‐mediated bone resorption in periodontal diseasePeriodontology 2000, 2007
- The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategiesJournal of Clinical Periodontology, 2007
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- B and T Lymphocytes Are the Primary Sources of RANKL in the Bone Resorptive Lesion of Periodontal DiseaseThe American Journal of Pathology, 2006
- OsteoimmunologyImmunological Reviews, 2005
- Determination of lymphocyte populations and subpopulations extracted from chronically inflamed human periodontal tissuesJournal of Clinical Periodontology, 1992
- Polyclonal B‐cell activation in periodontitis*Journal of Periodontal Research, 1989
- Phenotypic analyses of mononuclear cells recovered from healthy and diseased human periodontal tissuesJournal of Clinical Immunology, 1987
- Experimental gingivitis in humans.Journal of Periodontal Research, 1983